2 results

• FDA Finds No New Problems With Zyprexa Relprevv After Safety Review

  March 24, 2015

  Irvin Jackson

  An FDA review has determined that Zyprexa Relprevv needs no new label warning following two patient deaths.

• Long-Acting Zyprexa Relprevv Deaths Result in FDA Warning

  June 19, 2013

  Irvin Jackson

  The FDA has launched an investigation into Zyprexa Relprevv, a long-acting antipsychotic, after two patients were found dead days after receiving injections.